Brief: Tianjin Development Announces Disposal Of 15% Equity Interest In Tianjin Pharmaceutical Finance
25/08/2023 02:47
Aug 25 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* POTENTIAL DISPOSAL OF 15% EQUITY INTEREST IN TIANJIN
PHARMACEUTICAL GROUP FINANCE CO., LTD. HELD BY TIANJIN LISHENG
PHARMACEUTICAL CO., LT
* DEAL FOR RMB87.8 MILLION
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln